Drew Sanders/PitchBook
Just over a decade ago, one in eight US adults owned a wearable. Today, it’s closer to one in two, and most of them never take it off.
Millions of people use the devices to monitor everything from sleep quality to heart rate variability. Investors are about to take its pulse: the sector faces its biggest test since Fitbit‘s 2015 IPO, as smart ring maker Oura prepares to go public.
In 2015, the Finnish-born company sold its first sleep tracker through a Kickstarter campaign that raised $650,000. Now headquartered in both San Francisco and Oulu, Finland, it’s gearing up for a listing as early as this month that could value it at up to $16 billion, nearly four times what Fitbit achieved.
In its S-1, Oura describes itself as “an always-on health intelligence platform,” emphasizing its data and intelligence capabilities and its “highly retentive” subscription model.
“Oura is the first real public test of this newer wearable category at scale, so everyone’s watching,” said Mike Collett, founder and managing partner of Promus Ventures, which invested in fitness wearable Whoop. “If it prices well, it reprices the whole space and pulls the next wave of wearable companies toward the public markets. A strong print from Oura further cements the market’s view of the wearable story.”
The money is moving
Investment in wearables and quantified self startups has reached $4.1 billion this year, according to PitchBook data, with several large deals closing, including smart health tracker Whoop’s $575 million Series G.
The current pace of VC funding in the sector hasn’t been seen since the sector’s 2021 peak, but investors say the environment is very different.
“The Covid boom was a hardware demand spike where people bought devices out of health anxiety, but a lot of those devices ended up in a drawer,” said Craig Shapiro, managing partner of Collaborative Fund, which led Whoop’s Series G. “What’s different now is the way these devices have become an essential part of people’s daily lives.”
Few areas of digital health have the traction that wearables have achieved. According to a Rock Health survey, 83% of wearable owners wear their devices for five or more days per week, and nearly half have used their devices for three or more years. Oura reported that its rings average 23.8 hours of daily wear time.
The sector has been helped by lower hardware costs than in the previous surge, but the real value, according to Shapiro, lies beyond the device.
“Hardware is the distribution channel and potentially a sensing moat, but it’s the recurring intelligence layer, and subscription multiple that goes with it, that will determine long-term value,” he said.
The data moat
Data transforms a wearable device from an accessory into a sticky product. A ring or a watch worn every day for years gives consumers a more accurate picture of their health, which influences their health choices—59% of owners have discussed their data with healthcare providers. It also significantly increases retention rates.
Abhishek Sharma, a partner at Nexus Venture Partners, an investor in smart ring startup Ultrahuman, says a $300 to $400 device covers customer acquisition costs on day one. The subscription that follows, built on data, is worth three to four times the device’s gross profit over the life of the user.
Oura’s S-1 numbers reflect the growing importance of its subscription revenue. For the nine months ended June 30, hardware revenue totalled $974 million, representing 80% of overall revenue. While membership revenue was only $240.5 million, it increased 121% year-over-year, compared to 65% for hardware.
According to Collett, the value of data is only increasing with innovations in AI.
"[There are] three places now where [AI] is showing up fastest,” he said. “One, personalization, coaching that adapts to your body instead of a generic average. Two, prediction, catching illness or a cardiac event before symptoms show. Three, the interface, an AI you talk to about your own data. AI is what moves a wearable from a dashboard you check to a system that tells you something you didn’t know. That’s the real prize, and it’s why the data moat is the whole game.”
Having a proprietary data edge is showing up in valuations, according to Collett, and the names with a real moat and durable retention are commanding premiums. Without that, companies are priced toward hardware comps, which are much lower.
Not every claim to a data moat holds up equally well, though. “Every company in the category talks about a data moat, so that claim gets checked the same way regardless of who makes it,” said Sharma. “More users do not automatically mean better output.”
However, startups with real data moats make the space more difficult to compete in, particularly for new entrants. An early-stage startup developing a smart ring has to go head-to-head with more mature rivals like Oura and Whoop, which already have years of customer data feeding their dashboard and analytics.
The likelihood of a user moving to a new service that wouldn’t have the personalization that comes with that data is low. The Rock Health survey found that fewer than one in four wearables users switch brands.
The brand itself also matters more than investors think, says Shapiro. Building a membership that people renew every month is a real challenge for new entrants.
Where capital goes next
According to Sharma, there is still room for newcomers in the health space for wearables startups.
“Within health, the products worth backing help with a specific decision rather than a dashboard,” he said. “Examples are women’s health across life stages, support during metabolic treatment, and monitoring linked to a care provider. Biochemical sensing has real potential, but a lab result is not a product till it works in the field and can be built at 100,000-plus units.”
Shapiro also identified women’s health tracking and neuro-sensing hearables—earbuds or headphones that non-invasively record electrical brain activity—as areas of opportunity.
One of the fastest-growing segments within the wearables market is smart glasses. Last month, US-based Legato raised $12 million for its frames that integrate hearing-assistance technology into the arms. French startup ENGO secured €5.1 million (about $5.9 million) in July for its AR glasses for athletes, which project performance data directly into the field of view.
Significant funding is also being raised outside health and wellness. Shenzhen-based Even Realities hit unicorn status in July, following a $150 million pre-Series B. Its glasses show notifications, live translations and navigation prompts. Early this year, Beijing-based Xreal raised $100 million for its AR glasses.
Sharma expects a new wave of wearables funding to move beyond health tracking and consumers.
“A wearable can also be used to control things, not only to record them,” he said. “EMG wristbands that read muscle activity and turn small movements into commands are already shipping.”
He added: “Enterprise needs a clear economic buyer. Defense and industrial customers already pay for wearables that can measure the results. If a customer can measure fewer errors or fewer injuries, that is something a business investor can price, even if it is less visible than consumer.”
Oura’s IPO will be a real test of how public markets receive a wearables company, and a clearer signal of what kind of returns the space can deliver for investors. But even if it disappoints, Collett doesn’t think that changes the underlying momentum.
“Either way, I see the demand underneath this industry continuing regardless [of Oura’s listing],” he said. “IPO windows open and close on sentiment. People wanting to understand their own bodies at a deeper, more granular level will continue well into the future.”
Recent News
Apollo views daily pricing as key to expanding alternatives access. Industry peers are skeptical.
Slush investors point to hardware and deep tech for defensibility
Learn about our editorial standards.